BMFC2026 Registration
Taking place in Amsterdam from 29-30 September 2026, we are delighted to invite you to join us at this year’s Better Medicines for Children Conference.
To make your booking, please click the link below to visit the EFGCP website. You will be asked to log in to your EFGCP account, or create one if you are a new user, before completing your registration.
An EFGCP account is required to register for the event and provides access to important event services, including invoicing, post-event presentations and recordings, and any applicable membership benefits or fee reductions.
For any questions, please contact events@efgcp.eu
Registration Fees
Early Bird Registration fees are available until May 30th 2026.
All fees are VAT Excl. unless specified. 21% Belgian VAT will be applied on all registration fees, VAT Withdrawal or Reverse charge are not available for Face to Face Events.
Industry Group Fees: Reductions can be applied for group registrations, please contact events@efgcp.eu for more information:
3 participants – 10% | 5 participants – 15% | 7+ participants – 20%
For Commercial Stakeholders: Pharmaceutical Industry | Medical Device Industry | CRO Industry | Service Provider Company | Consultant | Insurance Company
| Members | Regular | |
| Full Conference | 675.00 € (816.75 € VAT Incl.) | 825,00 € (998.25 € VAT Incl.) |
| Day 1 (29 Sept. 2026) | 400.00 € (484.00 € VAT Incl.) | 475.00 € (574.75 € VAT Incl.) |
| Day 2 (30 Sept. 2026) | 400.00 € (484.00 € VAT Incl.) | 475.00 € (574.75 € VAT Incl.) |
For Non-Commercial Stakeholders: Hospital Staff | Academic Organisation | Regulatory / Governmental Institution | Foundation | Medical Society | Public Organisation | Ethics Committee | Journalist | Patient Organisation / Advocate
| Members | Regular | |
| Full Conference | 200.00 € (242.00 € VAT Incl.) | 275.00 € (332.75 € VAT Incl.) |
For: Retired / Students (Attention, proof of studentship required)
| Any Stakeholders | |
| Full Conference | 200.00 € (242.00 € VAT Incl.) |
Online Attendance
While the conference will once again offer a hybrid format, we strongly encourage you to join us in person. Attending the event onsite provides an excellent opportunity to engage directly with key stakeholders in paediatric drug development and to build valuable connections with fellow delegates.
Please note: Online attendance will be view only. There will be no direct interaction with on site faculty.